QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bigner, S. H. Articles by McLendon, R. E. Search for Related Content PubMed PubMed Citation

Morphologic and molecular genetic aspects of oligodendroglial neoplasms

Department of Pathology, Duke University Medical Center, Durham, NC 27710

² Address correspondence and reprint requests to Sandra H. Bigner, MD, Duke University Medical Center, Box 3712, Durham, NC 27710.

Abstract

Morphologic criteria for diagnosing oligodendrogliomas and for classifying them as well-differentiated (World Health Organization grade II) and anaplastic (World Health Organization grade III) are well recognized. Nevertheless, applying these guidelines to specific cases often reveals discrepancies among different observers. In addition, whether a given tumor also contains an astrocytic component may be debatable. Loss of heterozygosity studies have demonstrated that oligodendroglial neoplasms have a high incidence of loss of the 1p and 19q chromosomal arms. Although loss of heterozygosity for portions of 19q are sometimes seen in astrocytic neoplasms, these tumors seldom show complete loss of 19q accompanied by loss of 1p. Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas. These observations suggest that molecular genetic parameters could provide an objective, reproducible framework for classifying oligodendroglial neoplasms.

This article has been cited by other articles:

				M. D. Jenkinson, D. G. du Plessis, T. S. Smith, K. A. Joyce, P. C. Warnke, and C. Walker Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features Brain, July 1, 2006; 129(7): 1884 - 1891. [Abstract] [Full Text] [PDF]

				K. A. Jaeckle, K. V. Ballman, R. D. Rao, R. B. Jenkins, and J. C. Buckner Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response J. Clin. Oncol., March 10, 2006; 24(8): 1246 - 1252. [Abstract] [Full Text] [PDF]

				M. D. Jenkinson, T. S. Smith, K. Joyce, D. Fildes, D. G. du Plessis, P. C. Warnke, and C. Walker MRS of oligodendroglial tumors: Correlation with histopathology and genetic subtypes Neurology, June 28, 2005; 64(12): 2085 - 2089. [Abstract] [Full Text] [PDF]

				C. Walker, D. G. du Plessis, D. Fildes, B. Haylock, D. Husband, M. D. Jenkinson, K. A. Joyce, J. Broome, K. Kopitski, J. Prosser, et al. Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component Clin. Cancer Res., November 1, 2004; 10(21): 7182 - 7191. [Abstract] [Full Text] [PDF]

				C. Walker, D. G. du Plessis, K. A. Joyce, Y. Machell, J. Thomson-Hehir, S. A. Al Haddad, J. C. Broome, and P. C. Warnke Phenotype versus Genotype in Gliomas Displaying Inter- or Intratumoral Histological Heterogeneity Clin. Cancer Res., October 15, 2003; 9(13): 4841 - 4851. [Abstract] [Full Text] [PDF]